Pertussis toxin-insensitive phosphoinositide hydrolysis, membrane depolarization, and positive inotropic effect of carbachol in chick atria.
Muscarinic agonists can stimulate rather than inhibit cardiac muscle in some preparations. In left atria from hatched chicks, treatment with pertussis toxin reversed the membrane action of carbachol from hyperpolarization to depolarization and reversed the inotropic effect of carbachol from negative to positive. Acetylcholine also depolarized the membrane and increased the force of contraction in atria from pertussis-toxin-treated chicks although oxotremorine did not. These cholinergic responses were blocked by atropine but not by adrenoceptor antagonists, suggesting that they are mediated via muscarinic receptors and are not due to actions of endogenously released catecholamines. Muscarinic receptor stimulation leads to two distinct biochemical responses in chick atria: inhibition of adenylate cyclase and activation of phosphoinositide (PI) hydrolysis. The former is lost in atria from pertussis-toxin-treated chicks, whereas the PI response persists. The pharmacologic characteristics of the PI response resemble those of the depolarization and positive inotropic response. Both are insensitive to blockade by pertussis toxin, require high concentrations of carbachol, and are elicited by acetylcholine but not by oxotremorine. The present study suggests that muscarinic agonist-induced PI turnover may be responsible for the membrane depolarization and positive inotropic effects of carbachol and acetylcholine; that an increase in Na+ conductance underlies these responses; and that it is stimulated either by an increase of intracellular calcium mobilized by inositol triphosphate and/or by activation by protein kinase C.
D037361:Adenylate Cyclase Toxin; D000818:Animals; D000831:Animals, Newborn / Q000378:metabolism / Q000502:physiology*; D002217:Carbachol / Q000494:pharmacology*; D002645:Chickens; D004594:Electrophysiology; D005110:Extracellular Space / Q000378:metabolism; D006321:Heart / Q000187:drug effects* / Q000502:physiology; D006325:Heart Atria; D006868:Hydrolysis; D008566:Membranes / Q000502:physiology; D009200:Myocardial Contraction; D009206:Myocardium / Q000378:metabolism*; D009994:Osmolar Concentration; D037342:Pertussis Toxin; D010716:Phosphatidylinositols / Q000378:metabolism*; D013779:Tetrodotoxin / Q000494:pharmacology; D014700:Verapamil / Q000494:pharmacology; D010566:Virulence Factors, Bordetella / Q000494:pharmacology*
D037361:Adenylate Cyclase Toxin; D010716:Phosphatidylinositols; D010566:Virulence Factors, Bordetella; D013779:Tetrodotoxin; D002217:Carbachol; D014700:Verapamil; D037342:Pertussis Toxin